
Overview
Elena Gelfand is a Nephrologist in Sacramento, California. Dr. Gelfand is rated as an Experienced provider by MediFind in the treatment of Diffuse Mesangial Sclerosis. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Hypophosphatemia. Dr. Gelfand is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
John Howard is a Nephrologist in Elk Grove, California. Dr. Howard is rated as an Advanced provider by MediFind in the treatment of Diffuse Mesangial Sclerosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Nephrotic Syndrome, and Congenital Nephrotic Syndrome. Dr. Howard is currently accepting new patients.
Tarang Patel is a Nephrologist in Sacramento, California. Dr. Patel has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Diffuse Mesangial Sclerosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Diabetic Nephropathy. Dr. Patel is currently accepting new patients.
Eric Chang is a Nephrologist in Sacramento, California. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Diffuse Mesangial Sclerosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Tubular Necrosis, and Diabetic Nephropathy. Dr. Chang is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Kidney DiseaseDr. Gelfand isDistinguished. Learn about Chronic Kidney Disease.
- End-Stage Renal Disease (ESRD)Dr. Gelfand isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- Advanced
- Acute Kidney FailureDr. Gelfand isAdvanced. Learn about Acute Kidney Failure.
- Acute Tubular NecrosisDr. Gelfand isAdvanced. Learn about Acute Tubular Necrosis.
- Childhood Hypophosphatasia (HPP)Dr. Gelfand isAdvanced. Learn about Childhood Hypophosphatasia (HPP).
- Hypophosphatasia (HPP)Dr. Gelfand isAdvanced. Learn about Hypophosphatasia (HPP).
- HypophosphatemiaDr. Gelfand isAdvanced. Learn about Hypophosphatemia.
- Juvenile Paget's DiseaseDr. Gelfand isAdvanced. Learn about Juvenile Paget's Disease.
- Experienced
- Congenital Nephrotic SyndromeDr. Gelfand isExperienced. Learn about Congenital Nephrotic Syndrome.
- Denys-Drash Syndrome (DDS)Dr. Gelfand isExperienced. Learn about Denys-Drash Syndrome (DDS).
- Diffuse Mesangial SclerosisDr. Gelfand isExperienced. Learn about Diffuse Mesangial Sclerosis.
- Feingold SyndromeDr. Gelfand isExperienced. Learn about Feingold Syndrome.
- Focal Segmental GlomerulosclerosisDr. Gelfand isExperienced. Learn about Focal Segmental Glomerulosclerosis.
- Frasier SyndromeDr. Gelfand isExperienced. Learn about Frasier Syndrome.

